Growing community of inventors

Hamburg, Germany

Michael Trautmann

Average Co-Inventor Count = 2.82

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 239

Michael TrautmannKenneth Francis Mace (2 patents)Michael TrautmannSteven Witt Dodd (2 patents)Michael TrautmannRichard Dennis DiMarchi (1 patent)Michael TrautmannMichael Rosario DeFelippis (1 patent)Michael TrautmannKingman Ng (1 patent)Michael TrautmannDennis Kim (1 patent)Michael TrautmannMichael Trautmann (4 patents)Kenneth Francis MaceKenneth Francis Mace (3 patents)Steven Witt DoddSteven Witt Dodd (2 patents)Richard Dennis DiMarchiRichard Dennis DiMarchi (111 patents)Michael Rosario DeFelippisMichael Rosario DeFelippis (7 patents)Kingman NgKingman Ng (3 patents)Dennis KimDennis Kim (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Eli Lilly and Company (3 from 4,447 patents)

2. Amylin Pharmaceuticals, Inc. (1 from 164 patents)

3. Astrazeneca Pharmaceuticals LP (1 from 38 patents)


4 patents:

1. 8501693 - Use of exendins and exendin agonists and GLP-1 receptor agonists for altering the concentration of fibrinogen

2. 7989585 - Chronic treatment regimen using glucagon-like insulinotropic peptides

3. 7259233 - Chronic treatment regimen using glucagon-like insulinotropic peptides

4. 7179788 - Biphasic mixtures of GLP-1 and insulin

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/1/2026
Loading…